Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.

Cocconi, G; Bisagni, G; Bacchi, M; Boni, C; Bartolucci, R; Ceci, G; Colozza, M A; De Lisi, V; Lottici, R; Mosconi, A M

Cocconi, G; Bisagni, G; Bacchi, M; Boni, C; Bartolucci, R; Ceci, G; Colozza, M A; De Lisi, V; Lottici, R; Mosconi, A M.

Affiliation

Cocconi G; Medical Oncology Service, University Hospital, Parma, Italy.

J Clin Oncol ; 9(4): 664-9, 1991 Apr.

Article in En | MEDLINE | ID: mdl-2066763

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adenocarcinoma/secondary; Adult; Aged; Breast Neoplasms/pathology; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Etoposide/administration & dosage; Female; Fluorouracil/administration & dosage; Humans; Methotrexate/administration & dosage; Middle Aged

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1991 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links